knowledge -WSS

knowledge

author：Wikipedia 2025-10-01 23:31:39 - browse：7

Balance innovation — Medicare laid out in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be. Adobe

WASHINGTON — Medicare laid out Wednesday in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be.

Democrats outlined some parts of the process in the Inflation Reduction Act that passed Congress last August, but the details of how drugs will be selected and what factors will be considered have been vague until now. Though the actual negotiated prices won’t take effect for years, Medicare officials must announce the first 10 drugs they’ll negotiate over by Sept. 1.

The guidance clarifies that the agency will choose the 50 pharmacy drugs that cost Medicare the most money, based on gross expenditures. If drugs have the same cost to the program, then the one that has been approved longer will be ranked higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： What affirmative action's end means to a medical student

WSS

Use doctors trained outside the U.S. to ease the physician shortage

Hubble vs. James Webb telescope images: See the difference

Hubble vs. James Webb telescope images: See the difference

A letter from the executive editor: The 2023 STATUS List

Cue Health, Covid

Bird flu surveillance in wastewater gets boost from consortium

knowledge

knowledge

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The wait for US passports is creating travel purgatory and snarling summer plans

Medicare details structure of new drug price negotiation program

Skip the lead apron during X

What does generative AI mean for health care? We asked experts

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Trump demands the U.S. pay no more for drugs than other countries … again

Listen: More tumult at BIO & coercive care for sickle cell patients

Guidelines to prevent youth baseball injuries need more muscle

ASCO eve: Let’s set the table for this year's meeting

hotspot

Drug cartel violence flares in western Mexico after vigilante leader's killing

'Screen and refer' systems are hurting patients

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Use doctors trained outside the U.S. to ease the physician shortage

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

As a primary care physician, here's how I hope to partner with AI

entertainment

entertainment

hotspot

leisure time